MarketPeel
Insider Trading Intelligence
Pricing
…
JA

Jason Aryeh

LGND
DIRECTOR · LIGAND PHARMACEUTICALS INC · CIK 0001376960
FILING MIX · LIFETIME82%/18%
BUYS
40
SELLS
9
TOTAL VALUE
$3.43M
COMPANIES
3
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
215,100
AVG SELL PX
$197.21
TRADE KIND
SHOWING 49 / 49
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Jason Aryeh, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+0.00%+2.65%+0.27%+2.38%+3.35%—
14d4+25.00%+8.26%+0.88%+7.39%+6.44%—
30d4+25.00%+21.38%+1.25%+20.12%+7.27%—
60d4+25.00%+30.90%-0.61%+31.51%+17.38%—
90d4+25.00%+31.47%+2.93%+28.54%+12.74%—
180d4+25.00%+34.27%-0.97%+35.24%+18.59%—
1y4(4 pending)——————
2y4(4 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LGND · 102,580 shares · as of Jun 11, 2026
026,89553,79080,685107,580202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 40 buys / 9 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
42,553——42,553Jun 23, 2026Jun 25, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
4,500$250.00$1.13M102,580Jun 11, 2026Jun 12, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
500$250.00$125.0K107,080Jun 10, 2026Jun 12, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
836——107,580Jun 5, 2026Jun 12, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,938——2,938Jun 5, 2026Jun 12, 2026 ↗View →
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
PURCHASEGRANT
Stock grant
25,907——69,967Jun 4, 2026Jun 5, 2026 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
665$3.75$2.5K118,118May 18, 2026May 20, 2026 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
8,971$3.90$35.0K117,453May 15, 2026May 19, 2026 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,034$69.51$141.4K71,323Dec 8, 2025Dec 8, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,034——0Dec 8, 2025Dec 8, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
4,628$170.96$791.2K70,243Sep 23, 2025Sep 24, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
954$171.92$164.0K69,289Sep 23, 2025Sep 24, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
4,418$170.41$752.8K74,871Sep 23, 2025Sep 24, 2025 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
1,000$2.45$2.5K108,482Sep 19, 2025Sep 19, 2025 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
15,000——107,482Aug 7, 2025Aug 8, 2025 ↗View →
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
PURCHASEGRANT
Stock grant
19,506——44,060Jul 15, 2025Jul 17, 2025 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
36,797——36,797Jun 24, 2025Jun 27, 2025 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
12,422——92,482Jun 24, 2025Jun 27, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,209——79,289Jun 6, 2025Jun 10, 2025 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,783——5,783Jun 6, 2025Jun 10, 2025 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
SALE
11,700——6,900Dec 27, 2024Dec 30, 2024 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
11,700$4.30$50.3K80,060Dec 27, 2024Dec 30, 2024 ↗View →
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
PURCHASEGRANT
Stock grant
24,554——24,554Aug 19, 2024Aug 21, 2024 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
17,068——17,068Jun 20, 2024Jun 21, 2024 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,376——68,360Jun 20, 2024Jun 21, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,444——5,444Jun 14, 2024Jun 18, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,252——78,080Jun 14, 2024Jun 18, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,406——0Apr 30, 2024May 2, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,406$52.30$125.8K76,828Apr 30, 2024May 2, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,893——0Mar 5, 2024Mar 6, 2024 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,893$39.35$113.8K74,422Mar 5, 2024Mar 6, 2024 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jul 20, 2023Jul 24, 2023 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,461——5,461Jun 9, 2023Jun 13, 2023 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,142——71,529Jun 9, 2023Jun 13, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
11,246——11,246Apr 12, 2023May 5, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASE
11,246——62,984Apr 12, 2023May 5, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
22,492——22,492Jan 26, 2023May 5, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
51,738——51,738Jan 26, 2023Jan 30, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
23,250——23,250Jan 26, 2023May 19, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
18,600——18,600Jan 26, 2023Jan 30, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
23,250——23,250Jan 26, 2023Jan 30, 2023 ↗View →
OBIO
ORCHESTRA BIOMED HOLDINGS, INC.
PURCHASEGRANT
Stock grant
6,975——6,975Jan 26, 2023Jan 30, 2023 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,484——4,484Dec 22, 2022Dec 27, 2022 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,340——4,340Jun 10, 2022Jun 13, 2022 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,004——69,668Jun 10, 2022Jun 13, 2022 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,269——3,269Jun 4, 2021Jun 7, 2021 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
630——68,664Jun 4, 2021Jun 7, 2021 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,468——2,468Jun 10, 2020Jun 12, 2020 ↗View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
831——68,034Jun 10, 2020Jun 12, 2020 ↗View →
Other insiders · LGND
Loading peer insiders…
About this filer
CIK 0001376960
ROLE
Director
PRIMARY
LGND
COMPANIES
3
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001376960DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback